Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort. - Wikidata - wikimedia - TriplyDB

Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.

Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.

http://www.wikidata.org/entity/Q37670725

about

Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.

http://www.wikidata.org/entity/Q37670725

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hormone receptor status and su ...... er patients. A Turkish cohort.

@en

Hormone receptor status and su ...... er patients. A Turkish cohort.

@nl

type

label

Hormone receptor status and su ...... er patients. A Turkish cohort.

@en

Hormone receptor status and su ...... er patients. A Turkish cohort.

@nl

prefLabel

Hormone receptor status and su ...... er patients. A Turkish cohort.

@en

Hormone receptor status and su ...... er patients. A Turkish cohort.

@nl

P1433

Q37670725-7F00415B-C0BF-46FA-BEB0-4CB473DDE21A

P1476

Q37670725-B9CBE901-BC2D-41C8-BA0D-F00BC36E9E40

P2093

Q37670725-14CDD174-A01E-4F45-A03E-8C593153178A

Q37670725-38B14781-FB9A-4E6A-91DA-D09A8BCA1349

Q37670725-48AF20A1-A0CC-46E0-8F08-6303B6DC8FB4

Q37670725-5B9E2FD7-81BF-4AFB-921F-81EAFB9DA055

Q37670725-79495F7A-7023-4FEA-946B-AD9A6E5E4032

Q37670725-98B4F03D-43DA-43C7-BA25-9FD92A800BDD

Q37670725-A8E30475-5DE8-47C7-8274-ED76004D3E06

Q37670725-B09CE440-53F3-4633-9B22-8FEEA2AEA9B7

Q37670725-B4D290BC-31B4-4DDC-9097-D98F77028EE1

Q37670725-BA3C812E-27FC-425A-845F-D4DA5B0724E5

P2860

Q37670725-023D1149-189B-468B-B614-E2B5FFE5AF8E

Q37670725-1C2F96BD-7908-46CA-9C89-40898855790A

Q37670725-212B105F-E17A-4B9C-8724-AA9D58DBCC25

Q37670725-26CC009A-430A-4ABE-BF2C-77E6C2B9C1A9

Q37670725-31A5B57B-7FDA-4D24-9D21-7DE384AB0090

Q37670725-46D344FB-8DDA-4A37-B0FC-6684B6771950

Q37670725-4B2C8CBF-D928-4773-BE40-F7C60AD0B0C4

Q37670725-5314ED00-025A-47E1-BDD3-92A3CCBD1133

Q37670725-53F0DCA5-5192-4727-9DA0-9B5F8DE40325

Q37670725-5749E5DF-3D4C-4588-ACFA-05069159C083

P304

Q37670725-7954218A-ADC7-4379-8B53-FE5632317E06

P31

Q37670725-83A757DB-E43F-48DC-91E8-BE58311C83BD

P356

Q37670725-6CC116F0-F4F0-4483-9CDF-F2963E79ACAB

P433

Q37670725-674C49F7-95E6-4255-9F8C-FEA22175DE33

P478

Q37670725-22011A64-81C5-42B1-8146-029B9FFE1E3D

P50

Q37670725-D91A607C-599E-4AD5-AAAC-84F263FCB551

P577

Q37670725-E368D09F-FC9F-4FB6-B785-706E3052FC86

P698

Q37670725-2A504908-172A-4AEF-A71C-FCEA6EBEEFAB

P932

Q37670725-099B7891-387C-4860-9E6C-64178F0F0F87

P356

SMJ.2017.2.18055

P1433

Saudi Medical Journal

P1476

Hormone receptor status and su ...... cer patients. A Turkish cohort

@en

P2093

Aydin Aytekin

http://www.w3.org/2001/XMLSchema#string

Erkan Arpaci

http://www.w3.org/2001/XMLSchema#string

Hatice Odabas

http://www.w3.org/2001/XMLSchema#string

Havva Y Cinkir

http://www.w3.org/2001/XMLSchema#string

Kezban N Pilanci

http://www.w3.org/2001/XMLSchema#string

Mahmut Gumus

http://www.w3.org/2001/XMLSchema#string

Mustafa Degirmenci

http://www.w3.org/2001/XMLSchema#string

Nilufer Avci

http://www.w3.org/2001/XMLSchema#string

Oktay Bozkurt

http://www.w3.org/2001/XMLSchema#string

Serap Kaya

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

CD317 Promotes the survival of cancer cells through apoptosis-inducing factor

A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition

Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.

Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases.

Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.

Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population

Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas

Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.

High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.

P304

156-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15537/SMJ.2017.2.18055

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28133688

http://www.w3.org/2001/XMLSchema#string

P932

5329627

http://www.w3.org/2001/XMLSchema#string